Skip to content

Study · Not a test of the peptide alone · 2025

4 results

TikTok's take on adverse effects for glucagon-like peptide-1 and gastric inhibitory polypeptide receptor agonists.

Wantuch GA, Singleton J

Journal of the American Pharmacists Association : JAPhA4 Mar 2025Cited by 3 (Europe PMC)

PMID40049364 (opens in a new tab)DOI10.1016/j.japh.2025.102384 (opens in a new tab)PepBankPUB-40049364
Publisher pagePubMedAsk about this study
Jump to 4 results

Summary

The text of this summary is not shown here, because the article license does not allow reuse. Read it at the source (opens in a new tab)

Text rights: Publisher copyright. Results still quote short attributed sentences.

Results from this study4

No result from this study comes from a test of the peptide.

Studies that did not test the peptide alone4

In this study, the peptide was a lab tool or a carrier, part of a mix, or the subject of a lab method. These results are not evidence about taking the peptide.

  1. 01HumanNot a test of Semaglutide aloneObservational studySafety outcome

    In 165 popular TikTok videos about GLP-1 and GIP receptor agonist side effects, all adverse effects mentioned in at least 5 videos aligned with package inserts, except insomnia.

    In plain wordsIn popular TikTok videos about GLP-1 and GIP drugs, the side effects people named matched package inserts, except insomnia. This covers the drug class.

    Peptide
    Semaglutide
    Outcome
    Not applicableAlignment of adverse effects in TikTok videos with package inserts
    Study

    n = 165

    Outcome group
    Adverse events · Whole body

    Source sentences

    Summary
    All adverse effects mentioned in at least 5 videos aligned with medication package inserts, most commonly gastrointestinal disturbances, except for insomnia.
    2 context sentences
    Summary · context
    This observational study evaluated videos for popular GLP-1 and GIP receptor agonist side-effect hashtags on TikTok, in June 2023.
    Summary · context
    A total of 165 videos were analyzed.

    In this study, Semaglutide was a lab tool or a carrier, part of a mix, or the subject of a lab method. This result is not evidence about taking Semaglutide.

  2. 02HumanNot a test of Tirzepatide aloneObservational studySafety outcome

    In 165 popular TikTok videos about GLP-1 and GIP receptor agonist side effects, all adverse effects mentioned in at least 5 videos aligned with package inserts, except insomnia.

    In plain wordsIn popular TikTok videos about GLP-1 and GIP drugs, the side effects people named matched package inserts, except insomnia. This covers the drug class.

    Peptide
    Tirzepatide
    Outcome
    Not applicableAlignment of adverse effects in TikTok videos with package inserts
    Study

    n = 165

    Outcome group
    Adverse events · Whole body

    Source sentences

    Summary
    All adverse effects mentioned in at least 5 videos aligned with medication package inserts, most commonly gastrointestinal disturbances, except for insomnia.
    2 context sentences
    Summary · context
    This observational study evaluated videos for popular GLP-1 and GIP receptor agonist side-effect hashtags on TikTok, in June 2023.
    Summary · context
    A total of 165 videos were analyzed.

    In this study, Tirzepatide was a lab tool or a carrier, part of a mix, or the subject of a lab method. This result is not evidence about taking Tirzepatide.

  3. 03HumanNot a test of Semaglutide aloneObservational studySafety outcome

    In 165 popular TikTok videos about GLP-1 and GIP receptor agonist side effects, insomnia was the one frequently mentioned adverse effect that did not align with package inserts.

    In plain wordsIn popular TikTok videos about GLP-1 and GIP drugs, insomnia was named often but did not match package inserts. This covers the drug class.

    Peptide
    Semaglutide
    Outcome
    Not applicableInsomnia mentioned in videos but not in package inserts
    Study

    n = 165

    Outcome group
    Adverse events · Whole body

    Source sentences

    Summary
    All adverse effects mentioned in at least 5 videos aligned with medication package inserts, most commonly gastrointestinal disturbances, except for insomnia.
    2 context sentences
    Summary · context
    This observational study evaluated videos for popular GLP-1 and GIP receptor agonist side-effect hashtags on TikTok, in June 2023.
    Summary · context
    A total of 165 videos were analyzed.

    In this study, Semaglutide was a lab tool or a carrier, part of a mix, or the subject of a lab method. This result is not evidence about taking Semaglutide.

  4. 04HumanNot a test of Tirzepatide aloneObservational studySafety outcome

    In 165 popular TikTok videos about GLP-1 and GIP receptor agonist side effects, insomnia was the one frequently mentioned adverse effect that did not align with package inserts.

    In plain wordsIn popular TikTok videos about GLP-1 and GIP drugs, insomnia was named often but did not match package inserts. This covers the drug class.

    Peptide
    Tirzepatide
    Outcome
    Not applicableInsomnia mentioned in videos but not in package inserts
    Study

    n = 165

    Outcome group
    Adverse events · Whole body

    Source sentences

    Summary
    All adverse effects mentioned in at least 5 videos aligned with medication package inserts, most commonly gastrointestinal disturbances, except for insomnia.
    2 context sentences
    Summary · context
    This observational study evaluated videos for popular GLP-1 and GIP receptor agonist side-effect hashtags on TikTok, in June 2023.
    Summary · context
    A total of 165 videos were analyzed.

    In this study, Tirzepatide was a lab tool or a carrier, part of a mix, or the subject of a lab method. This result is not evidence about taking Tirzepatide.

AI wrote and checked these results. AI can make mistakes, so check important results against the source.

Version history

PepBank keeps every version of the data on this study. Status changes from Retraction Watch, Europe PMC and Crossref are listed with their source.

  1. Version 3Current

    11 Oct 2026, 00:04 UTC

    Study results updated

  2. Version 2

    9 Oct 2026, 03:07 UTC

    Study data updated · source update from Europe PMC

  3. Version 1

    9 Oct 2026, 03:06 UTC

    First added · source update from Europe PMC

Subjects

Terms as the source lists them.

PepBank is a research reference. Talk to a doctor before you use any peptide.